Sign up for email alert when new content gets added: Sign up
Shen-Yuan Yuan
Beijing Tongren Hospital-Capital Medical University, China
Keynote: Curr Res Integr Med
To assess whether multifactorial interventions have long-term effects on the risk of diabetes-related macro-vascular complications in patients with type-2 diabetes mellitus living in urban communities of Beijing. A total of 2926 patients with type-2 diabetes from 15 community health centers were divided into a Diabetes Mellitus (DM) group (n=824), a Hypertension (HTN) group (n=1267) and a Cardiovascular Disease (CVD) group (n=835). By applying Framingham Risk Scores (FRS), patients in the 3 groups were subdivided into low (FRS <10%), medium (FRS 10%-20%) and high (FRS >20%) Framingham risk strata. After 48 months, patients were followed-up to assess the long-term effects of the multifactorial interventions. At baseline, the patients� mean Neck Circumference (NC) was significantly higher in the HTN and CVD groups than in the DM group (P<0.05). After 48 months of follow-up, the CVD and HTN groups both had higher blood pressures and lipid levels than the DM group (both P<0.01). Although there was no significant change in the FRS versus baseline in the low and medium Framingham risk strata, a significant reduction in FRS was noted in the high Framingham risk strata. In Cox multivariate analyses, the HTN and CVD groups had higher incidences of endpoint events than the DM group. This study has demonstrated for the first time a relationship between NC and CVD in diabetic patients. Multifactorial interventions for CVD risk factors over 48 months lowered the estimated 10-year risk for CVD events in diabetes. FRS score influences the incidence of CVD events in diabetic patients. Aggressive risk reduction should be focused on these individuals who had high FRS score.
Shen-Yuan Yuan is the Professor and Chief Physician of Internal Medicine, Beijing Tongren Hospital, Capital Medical University, China. He has served as the Director of Internal Medicine, Director of Digestive Science and Director of Endocrinology in Beijing Tongren Hospital. He has won 21 awards, including the first Prize, the second prize and the third prize of Beijing Municipal Science and Technology Progress. Currently he is the Principal Leader of Beijing Community Diabetes Study (BCDS, 2008-2018) and the BRIDGES project from the International Diabetes Federation.
E-mail: fulvic@126.com